Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
China Healthwise Holdings ( (HK:0348) ) has provided an announcement.
China Healthwise Holdings has scheduled a board meeting for 27 March 2026 to review and approve the group’s annual results for the financial year ended 31 December 2025. The board will also consider the recommendation of a final dividend, if any, and handle other related corporate matters, signaling upcoming disclosures that may affect shareholder returns and market perception.
The announcement confirms the current composition of the company’s board, listing both executive and independent non-executive directors, which underscores its existing governance framework. Investors and other stakeholders will be watching the forthcoming results and any dividend decision for indications of operational performance and the company’s capital allocation priorities.
The most recent analyst rating on (HK:0348) stock is a Hold with a HK$0.14 price target. To see the full list of analyst forecasts on China Healthwise Holdings stock, see the HK:0348 Stock Forecast page.
More about China Healthwise Holdings
China Healthwise Holdings Limited is a Hong Kong-listed company incorporated in the Cayman Islands and traded under stock code 348. The group operates through a board comprising executive and independent non-executive directors, led by Chairman and Executive Director Lei Hong Wai, with a corporate structure that includes various subsidiaries.
Average Trading Volume: 249,000
Technical Sentiment Signal: Sell
Current Market Cap: HK$94.77M
See more data about 0348 stock on TipRanks’ Stock Analysis page.